MX2021013447A - Composiciones y procedimientos para el tratamiento de enfermedades oculares. - Google Patents
Composiciones y procedimientos para el tratamiento de enfermedades oculares.Info
- Publication number
- MX2021013447A MX2021013447A MX2021013447A MX2021013447A MX2021013447A MX 2021013447 A MX2021013447 A MX 2021013447A MX 2021013447 A MX2021013447 A MX 2021013447A MX 2021013447 A MX2021013447 A MX 2021013447A MX 2021013447 A MX2021013447 A MX 2021013447A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- methods
- ocular diseases
- treatment
- disclosure relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts or implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962842995P | 2019-05-03 | 2019-05-03 | |
| PCT/US2020/030691 WO2020227002A1 (en) | 2019-05-03 | 2020-04-30 | Compositions and methods for treatment of ocular diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021013447A true MX2021013447A (es) | 2022-02-11 |
Family
ID=70861542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021013447A MX2021013447A (es) | 2019-05-03 | 2020-04-30 | Composiciones y procedimientos para el tratamiento de enfermedades oculares. |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11376214B2 (https=) |
| EP (1) | EP3962452A1 (https=) |
| JP (1) | JP7334266B2 (https=) |
| KR (2) | KR102649858B1 (https=) |
| CN (1) | CN114025742A (https=) |
| CA (1) | CA3139060A1 (https=) |
| IL (1) | IL287802B2 (https=) |
| MX (1) | MX2021013447A (https=) |
| WO (1) | WO2020227002A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10945858B2 (en) * | 2010-09-03 | 2021-03-16 | Globus Medical, Inc. | Expandable interspinous process fixation device |
| GB202008857D0 (en) * | 2020-06-11 | 2020-07-29 | Univ Birmingham | Fluid gel compositions |
| GB202008853D0 (en) * | 2020-06-11 | 2020-07-29 | Univ Birmingham | Fluid gel compositions |
| CN112587475B (zh) * | 2020-12-18 | 2022-09-13 | 华熙生物科技股份有限公司 | 一种载药凝胶及其制备方法 |
| DE102023116924A1 (de) * | 2023-06-27 | 2025-01-02 | Carl Zeiss Meditec Ag | Kit zur Verwendung in einer Augenoperation und ophthalmische viskoelastische Vorrichtung |
| WO2025155730A1 (en) * | 2024-01-16 | 2025-07-24 | Regents Of The University Of Minnesota | Injectable hydrogel for embolization |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE312076T1 (de) * | 2001-02-22 | 2005-12-15 | Anika Therapeutics Inc | Thiol-modifizierte hyaluronan-derivate |
| CA2703807C (en) * | 2010-05-12 | 2017-10-24 | Molly S. Shoichet | Enhanced stability of inverse thermal gelling composite hydrogels |
| US10137199B2 (en) * | 2013-05-14 | 2018-11-27 | Biotime, Inc. | Thiolated hyaluronan-based hydrogels cross-linked using oxidized glutathione |
| US9782345B2 (en) * | 2013-10-17 | 2017-10-10 | Jade Therapeutics, Inc. | Ocular composition and method |
| EP3675873A4 (en) * | 2017-09-01 | 2021-06-16 | Pmidg, Llc | Functionalized and crosslinked polymers |
| US12029753B2 (en) * | 2017-09-19 | 2024-07-09 | The Hong Kong University Of Science And Technology | Biocompatible material and methods for making and using thereof |
-
2020
- 2020-04-30 KR KR1020217039722A patent/KR102649858B1/ko active Active
- 2020-04-30 JP JP2021565092A patent/JP7334266B2/ja active Active
- 2020-04-30 WO PCT/US2020/030691 patent/WO2020227002A1/en not_active Ceased
- 2020-04-30 EP EP20728846.5A patent/EP3962452A1/en not_active Withdrawn
- 2020-04-30 US US16/863,753 patent/US11376214B2/en active Active
- 2020-04-30 IL IL287802A patent/IL287802B2/en unknown
- 2020-04-30 KR KR1020247008519A patent/KR20240038152A/ko active Pending
- 2020-04-30 CN CN202080044610.5A patent/CN114025742A/zh active Pending
- 2020-04-30 CA CA3139060A patent/CA3139060A1/en active Pending
- 2020-04-30 MX MX2021013447A patent/MX2021013447A/es unknown
-
2022
- 2022-05-27 US US17/827,154 patent/US20220287961A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL287802B1 (en) | 2024-05-01 |
| KR20220004753A (ko) | 2022-01-11 |
| WO2020227002A1 (en) | 2020-11-12 |
| CA3139060A1 (en) | 2020-11-12 |
| JP7334266B2 (ja) | 2023-08-28 |
| IL287802A (en) | 2022-01-01 |
| CN114025742A (zh) | 2022-02-08 |
| US20200345634A1 (en) | 2020-11-05 |
| US11376214B2 (en) | 2022-07-05 |
| KR20240038152A (ko) | 2024-03-22 |
| JP2022530837A (ja) | 2022-07-01 |
| EP3962452A1 (en) | 2022-03-09 |
| IL287802B2 (en) | 2024-09-01 |
| US20220287961A1 (en) | 2022-09-15 |
| KR102649858B1 (ko) | 2024-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021013447A (es) | Composiciones y procedimientos para el tratamiento de enfermedades oculares. | |
| MX2020001340A (es) | Modelos celulares y terapias para enfermedades oculares. | |
| EP4338804A3 (en) | Epinephrine spray formulations | |
| MX2020006128A (es) | Inhibidores de la proteina de activacion de fibroblastos. | |
| PH12021550621A1 (en) | Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness | |
| EP4566651A3 (en) | Ophthalmic delivery device | |
| MX2020008680A (es) | Terapia de combinacion con apilimod y agentes glutamatergicos. | |
| HK1258588A1 (zh) | 用於治疗眼科疾病的化合物和制剂 | |
| WO2019157495A3 (en) | Methods for preventing and/or treating bone loss conditions by modulating irisin | |
| EP4324454A3 (en) | Cross-linking agents and associated methods | |
| MX2022000310A (es) | Inhibidores de proteina bcl-2. | |
| WO2019209948A8 (en) | Compounds and uses thereof | |
| BR112017015387A2 (pt) | composição em gel tópica, método de tratamento de uma infecção da pele, composição em gel oftálmica, e, método de tratamento de uma afecção infecciosa do olho ou pálpebra | |
| AU2018236629A8 (en) | Hydrogel patch | |
| WO2018208793A8 (en) | S-NITROSOGLUTATHIOME INHIBITORS (GSNO) AND GSNO REDUCTASE USEFUL IN THERAPY | |
| WO2023064278A3 (en) | Compositions and methods that inhibit il-23 signaling | |
| EP4582446A3 (en) | Methods of treating al amyloidosis | |
| MX2021004819A (es) | Composiciones y metodos para tratar lesiones cerebrales. | |
| EP4461211A3 (en) | Treatment of acute medical conditions | |
| JOP20200253A1 (ar) | تركيبات وطرق لعلاج الحثل البقعي | |
| MX355853B (es) | Composicion oftalmica para el tratamiento de infeccion ocular. | |
| WO2019043649A3 (en) | ANGIO -3 FOR THE TREATMENT OF RETINAL ANGIOGENIC DISEASES | |
| WO2019099860A3 (en) | Wound treatment containing collagen and a gelatin-reducing agent, and method for promoting wound healing | |
| WO2019236765A8 (en) | Acylated catechin polyphenols and methods of their use for the treatment of cancer | |
| MX2021002112A (es) | Uso de agonistas del receptor alfa-2-adrenergico para mejorar la vision. |